Susquehanna International Group’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.3K | Buy |
6,659
+1,247
| +23% | +$6.61K | ﹤0.01% | 6083 |
|
|
2025
Q1 | $23.9K | Buy |
+5,412
| New | +$23.9K | ﹤0.01% | 6131 |
|
|
2024
Q4 | – | Sell |
-2,816
| Closed | -$40.8K | – | 6875 |
|
|
2024
Q3 | $40.8K | Buy |
2,816
+831
| +42% | +$12.1K | ﹤0.01% | 5318 |
|
|
2024
Q2 | $145K | Buy |
+1,985
| New | +$145K | ﹤0.01% | 4933 |
|
|
2024
Q1 | – | Sell |
-3,373
| Closed | -$247K | – | 6666 |
|
|
2023
Q4 | $247K | Buy |
3,373
+2,117
| +169% | +$155K | ﹤0.01% | 4760 |
|
|
2023
Q3 | $48.8K | Sell |
1,256
-3,877
| -76% | -$151K | ﹤0.01% | 5127 |
|
|
2023
Q2 | $296K | Sell |
5,133
-8,484
| -62% | -$490K | ﹤0.01% | 4240 |
|
|
2023
Q1 | $885K | Buy |
13,617
+9,088
| +201% | +$591K | ﹤0.01% | 3066 |
|
|
2022
Q4 | $125K | Buy |
4,529
+1,029
| +29% | +$28.3K | ﹤0.01% | 4832 |
|
|
2022
Q3 | $102K | Buy |
3,500
+2,039
| +140% | +$59.4K | ﹤0.01% | 5267 |
|
|
2022
Q2 | $28K | Buy |
+1,461
| New | +$28K | ﹤0.01% | 5357 |
|
|
2021
Q4 | – | Sell |
-5,628
| Closed | -$703K | – | 6498 |
|
|
2021
Q3 | $703K | Buy |
5,628
+4,410
| +362% | +$551K | ﹤0.01% | 3235 |
|
|
2021
Q2 | $138K | Sell |
1,218
-62
| -5% | -$7.03K | ﹤0.01% | 4985 |
|
|
2021
Q1 | $194K | Buy |
+1,280
| New | +$194K | ﹤0.01% | 4806 |
|